Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Biotechnology Health care industry Pharmaceuticals
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Health care industry Biotechnology Business News
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe Markets Markets Novo Nordisk A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Health & Science Business News Companies
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Business News Investment Strategy stocks
From CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
Tags Science Biotech and Pharmaceuticals Business
From CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
Tickers RH
Tags Signet Jewelers Ltd Investment Strategy stocks
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Health & Science Merck & Co Inc Healthy Returns
From CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Tags Eli Lilly and Co Technology Alphabet Inc
From CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Alphabet Inc Eli Lilly and Co Breaking News: Technology
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Personnel Employee benefits Small Business Playbook
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Eli Lilly and Co Business Novo Nordisk A/S
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Chugai Pharmaceutical Co Ltd U/S/ Markets Investment strategy
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Hospitals Mobile Health care industry
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags Health care industry Biotechnology US: News
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Business News Investment Strategy stocks
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Breaking News: Investing AstraZeneca PLC Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Eli Lilly and Co Biotech and Pharmaceuticals Uber Technologies Inc
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Roche Holding AG Biotechnology Health care industry
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Health care industry Biotechnology Social issues
From CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
Tags Breaking News: Technology Tesla Inc Alphabet Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Eli Lilly and Co Biotech and Pharmaceuticals Apple Inc
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Zealand Pharma A/S AstraZeneca PLC Viking Therapeutics Inc
From CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
Tags Technology Executive Council Pharmaceuticals AI / Artificial Intelligence
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Health & Science Companies Business News
From CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
Tags Biotech and Pharmaceuticals Europe Markets Pharmaceuticals
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Breaking news Health & Science Companies
From CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
Tags Earnings Biotechnology Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.